2012
DOI: 10.1136/bmj.e2488
|View full text |Cite
|
Sign up to set email alerts
|

Is spending on proton beam therapy for cancer going too far, too fast?

Abstract: Both the US and UK are pouring money into proton accelerators, which have been described as the world’s “most costly medical devices.” Keith Epstein asks if the investment is premature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 4 publications
0
10
0
Order By: Relevance
“…In addition, establishing a European Hadron Therapy Register (or better, an International Register) to make better use of the data being generated by the many existing hadron therapy centers would be greatly beneficial. A further controversial article was published in the Biology and Medicine Journal (entitled "Is spending on proton beam therapy for cancer going too far too fast" [129]. However, in answer to this paper, a group of UK oncologists claimed the report misrepresented the approach being used in the UK [130].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, establishing a European Hadron Therapy Register (or better, an International Register) to make better use of the data being generated by the many existing hadron therapy centers would be greatly beneficial. A further controversial article was published in the Biology and Medicine Journal (entitled "Is spending on proton beam therapy for cancer going too far too fast" [129]. However, in answer to this paper, a group of UK oncologists claimed the report misrepresented the approach being used in the UK [130].…”
Section: Discussionmentioning
confidence: 99%
“…[48][49][50][51][52] With the more popular use of proton treatment, the cost-effectiveness comparisons between proton and X-ray treatment attract a lot of attention, especially on some specific sites such as left side breast cancer, head and neck cancer, pediatric cancer, and prostate cancer. [53] For left breast cancer and head and neck cancer, a series report by Lundkvist et al showed incremental cost-effectiveness ratio (iCER, cost/life years gain) of 34290 and 3811, respectively. [54,55] The assumption of their model included reducing the risks of ischemic heart disease, other cardiovascular diseases, and pneumonitis by proton treatment.…”
Section: Cost-effectiveness Consideration For Proton Therapymentioning
confidence: 99%
“…The cost of proton therapy for prostate cancer is typically about twice as much as conventional radiation, three times that of surgery, and 4-5 times that of brachytherapy 9 . In June 2011, a study of prostate cancer patients receiving conventional radiation showed fewer gastrointestinal problems than a similar group treated with proton beams.…”
Section: Proton Beam Therapymentioning
confidence: 99%
“…PBT is also predicted to be useful for children with brain tumours because of its reduced impact on subsequent neuropsychological and IQ development. However, randomized controlled trials (RCT) are required at various PBT centres to examine and evaluate the longterm effects and benefits, so as to establish a strong clinical efficacy and toxicity of PBT, and answer the questions raised and clarify the doubts expressed by a few critics 9 . For example, in hypoxic tumours such as head and neck cancer, Edinburgh randomized trial studies to compare fast neutrons (with high RBE) and photons showed that local control was similar but late severe radiation morbidity was significantly high in the neutrontreated patients 10 .…”
Section: Proton Beam Therapymentioning
confidence: 99%